🔎 Trials Near Me

Home › Prostate Cancer › Arizona › Scottsdale

Prostate Cancer clinical trials in Scottsdale, AZ

17 studies for Prostate Cancer are looking for participants at sites in and around Scottsdale (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer

RecruitingPhase 3
  • Mayo Clinic in Arizona, Scottsdale
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT06625034

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2
  • Mayo Clinic in Arizona, Scottsdale
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

RecruitingPhase 3
  • Mayo Clinic, Scottsdale
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT01492972

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

RecruitingPhase 3
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Scottsdale
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Recruiting
  • Mayo Clinic, Scottsdale
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06511141

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

RecruitingPhase 1
  • HonorHealth, Scottsdale
Ages 18 and older · Men · Updated Sep 8, 2026 · NCT05800665

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

RecruitingPhase 1/2
  • Honor Health Research Institute, Scottsdale
Ages 18 and older · Men · Updated Sep 4, 2026 · NCT07567846

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

RecruitingPhase 2
  • HonorHealth Research Institute, Scottsdale
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • Honor Health, Scottsdale
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

RecruitingEarly phase 1
  • Mayo Clinic in Arizona, Scottsdale
Ages 18 and older · Men · Updated Jun 8, 2026 · NCT05045066

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

RecruitingPhase 4
  • Mayo Clinic Arizona, Scottsdale
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

RecruitingPhase 1
  • HonorHealth Research Institute, Scottsdale
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT06778863

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

RecruitingPhase 4
  • Scottsdale Medical Imaging, LLC, Scottsdale
Ages 18 to 64 · All sexes · Updated Jan 22, 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Scottsdale
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Scottsdale

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.